You are now viewing 1 - 10 of 23 results
January 11, 2010 | Journal Article
The 2005 US Food and Drug Administration (FDA) "black box" advisory warning that atypical antipsychotic drugs increased risk of death with elderly patients with dementia led to fewer mentions of the drugs by physicians in the four years after implementation of the drug label requirement.
January 1, 2010 | Journal Article
The medical profession and pharmaceutical industry have fallen short in reducing the influence of gifts on prescription practices through self-regulation. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession.
June 1, 2013 | Journal Article
This study looked at the nutritional quality of menu offerings at eight fast-food restaurant chains over 14 years.
June 21, 2012 | Journal Article
Biomarkers may prove important in medicine, but controversy about biomarker patents has increased in recent years.
September 1, 2011 | Journal Article
Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.
May 4, 2013 | Journal Article
Better labeling and more stringent regulation are warranted for energy drinks.
May 1, 2013 | Journal Article
A harm-reduction model where the marketing is handled by a nonprofit entity is needed to align with the goals of reducing tobacco-related harm.
May 1, 2013 | Journal Article
The FCTC guidelines acknowledge that ‘there is a fundamental and irreconcilable conflict between the tobacco industry’s interests and public health policy interests’.
May 1, 2013 | Journal Article
Reducing nicotine content over time, results in a lower intake of nicotine and nicotine dependence.
May 1, 2013 | Journal Article
A ‘sinking lid’ strategy is one option worth considering when investigating possible tobacco endgame strategies.